Lundbeck Poland Sp. z o.o. is a pharmaceutical company specializing in brain diseases. The company has over 70 years of neuroscience expertise and has developed and commercialized therapies for brain diseases. Lundbeck Poland Sp. z o.o.'s portfolio of products reaches more than 8 million people daily, with registered products in over 80 countries. The company's largest markets are in the US, China, Canada, Spain, Italy, France, Japan, Brazil, Australia, and South Korea. Lundbeck Poland Sp. z o.o. is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world, with a focus on contributing to future strategic directions and generating enablers that support drug discovery and development. Lundbeck Poland Sp. z o.o. is recognized as a partner within brain diseases and is committed to providing medicinal products, safeguarding the safety of patients, and fighting fraudulent drugs. The company is dedicated to advancing brain health and transforming lives, constantly working on the development of neurology and supporting the patient community. Lundbeck Poland Sp. z o.o. is also engaged in partnerships to address unmet mental health needs and raise awareness of mental health conditions.
Headquarters
Ul. Aleje Ujazdowskie 41
Warsaw; Mazowieckie;
Postal Code: 00-540
Contact Details: Purchase the Lundbeck Poland Sp. z o.o. report to view the information.
Website: http://www.lundbeck.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service